Molecular Formula | C2H3Cl3O |
Molar Mass | 149.4 |
Density | 1.56 g/mL at 20 °C (lit.) |
Melting Point | 17.8 °C (lit.) |
Boling Point | 152-154 °C (lit.) |
Flash Point | >230°F |
Water Solubility | Slightly soluble in water. |
Solubility | 83g/l |
Vapor Presure | 1 mm Hg ( 20 °C) |
Vapor Density | 5.16 (vs air) |
Appearance | Liquid |
Specific Gravity | 1.560 (20/4℃) |
Color | Clear colorless to light yellow |
Odor | ethereal odor |
Merck | 14,9638 |
BRN | 1697495 |
pKa | 12.24(at 25℃) |
PH | 5-6 (H2O, 20℃)(saturated solution) |
Storage Condition | Store below +30°C. |
Sensitive | Hygroscopic |
Refractive Index | n20/D 1.49(lit.) |
Physical and Chemical Properties | Colorless liquid. Melting point 19. Boiling Point 151-153 °c, 94-97 °c (16.67kPa). Relative density 1.57(20/20 C). Refractive index 1.4885. With alcohol, ether miscible, soluble in water, aqueous solution pH 5-6. Easy to absorb moisture, there is the smell of ether. |
Use | Used as a pharmaceutical Intermediate |
In vitro study | 2,2,2-trichloroethanol activates a nonclassical potassium channel in cerebrovascular smooth muscle and dilates the middle cerebral artery. |
Hazard Symbols | Xn - Harmful |
Risk Codes | R22 - Harmful if swallowed R41 - Risk of serious damage to eyes R67 - Vapors may cause drowsiness and dizziness |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S39 - Wear eye / face protection. |
UN IDs | 1760 |
WGK Germany | 1 |
RTECS | KM3850000 |
FLUKA BRAND F CODES | 3-21 |
TSCA | Yes |
HS Code | 29055910 |
Hazard Class | 8 |
Packing Group | III |
Toxicity | LDLo orl-rat: 500 mg/kg CRAAA7 17,258,38 |
NIST chemical information | information provided by: webbook.nist.gov (external link) |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
biological activity | 2,2,2-Trichloroethanol is the active form of sedative hypnotic agent Chloral Hydrate, it is an agonist of the non-classical K2P channel TREK-1 and TRAAK. |
uses | for organic synthesis, pharmaceutical intermediates. used as pharmaceutical intermediates |
production method | is obtained by reduction of trichloroacetaldehyde. |